These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18384708)

  • 1. The role of healthcare communications agencies in maintaining compliance when working with the pharmaceutical industry and healthcare professionals.
    Cairns A; Yarker YE
    Curr Med Res Opin; 2008 May; 24(5):1371-8. PubMed ID: 18384708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Above reproach: developing a comprehensive ethics and compliance program.
    Yuspeh A; Whalen K; Cecelic J; Clifton S; Cobb L; Eddy M; Fainter J; Packard J; Postal S; Steakley J; Waddey P
    Front Health Serv Manage; 1999; 16(2):3-38. PubMed ID: 10787844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corporate compliance: framework and implementation.
    Fowler N
    Radiol Manage; 1999; 21(1):50-3. PubMed ID: 10346652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organization ethics or compliance: which will articulate values for the United States' healthcare system?
    Mills AE; Spencer EM
    HEC Forum; 2001 Dec; 13(4):329-43. PubMed ID: 11925687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.
    Grundy Q; Tierney L; Mayes C; Lipworth W
    J Bioeth Inq; 2017 Dec; 14(4):541-553. PubMed ID: 28913595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning.
    Olson MJ; Faria EC; Hayes EP; Jolly RA; Barle EL; Molnar LR; Naumann BD; Pecquet AM; Shipp BK; Sussman RG; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S19-27. PubMed ID: 27233923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Professional Medical Associations and Industry Guideline Compliance.
    Siegel M; Stedman A; Smith KA
    Pediatrics; 2015 Sep; 136(3):528-33. PubMed ID: 26240214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
    Choudhry NK; Stelfox HT; Detsky AS
    JAMA; 2002 Feb; 287(5):612-7. PubMed ID: 11829700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceuticals in Australia: developments in regulation and governance.
    Lofgren H; Boer Rd
    Soc Sci Med; 2004 Jun; 58(12):2397-407. PubMed ID: 15081192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring a corporate compliance program for an IDS.
    Berkey MF
    Healthc Financ Manage; 1999 Jan; 53(1):50-3. PubMed ID: 10339165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing compliance programs that foster ethical behavior.
    Lovitky JA; Ahern J
    Healthc Financ Manage; 1999 Mar; 53(3):38, 40-2. PubMed ID: 10351054
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.